A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain Transduction
Background. Models of cancer-induced neuropathy are designed by injecting cancer cells near the peripheral nerves. The interference of tissue-resident immune cells does not allow a direct contact with nerve fibres which affects the tumor microenvironment and the invasion process. Methods. Anaplastic...
Saved in:
Main Authors: | Ahmad Maqboul, Bakheet Elsadek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2017/3517207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis
by: Eeva Moilanen, et al.
Published: (2017-09-01) -
Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy
by: Jean-Baptiste Delmotte, et al.
Published: (2018-01-01) -
Quality of Life in Painful Peripheral Neuropathies: A Systematic Review
by: Ayesha Girach, et al.
Published: (2019-01-01) -
Novel Frostbite Cooling Device for Real-time Assessment and Prevention of Chemotherapy-induced Peripheral Neuropathy
by: Yuki Matsui, MD, PhD, et al.
Published: (2025-01-01) -
Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy
by: Sandra A. S. van den Heuvel, et al.
Published: (2017-01-01)